Ignite Creation Date:
2025-12-24 @ 7:58 PM
Ignite Modification Date:
2026-01-04 @ 8:50 AM
Study NCT ID:
NCT04769804
Status:
UNKNOWN
Last Update Posted:
2021-04-26
First Post:
2021-02-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Gene Polymorphism in Tinea Versicolor
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D014010', 'term': 'Tinea Versicolor'}], 'ancestors': [{'id': 'D003881', 'term': 'Dermatomycoses'}, {'id': 'D009181', 'term': 'Mycoses'}, {'id': 'D001423', 'term': 'Bacterial Infections and Mycoses'}, {'id': 'D007239', 'term': 'Infections'}, {'id': 'D012874', 'term': 'Skin Diseases, Infectious'}, {'id': 'D012871', 'term': 'Skin Diseases'}, {'id': 'D017437', 'term': 'Skin and Connective Tissue Diseases'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'CASE_CONTROL'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 200}, 'patientRegistry': False}, 'statusModule': {'overallStatus': 'UNKNOWN', 'lastKnownStatus': 'RECRUITING', 'startDateStruct': {'date': '2019-11-01', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2021-02', 'completionDateStruct': {'date': '2021-11-01', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2021-04-22', 'studyFirstSubmitDate': '2021-02-21', 'studyFirstSubmitQcDate': '2021-02-21', 'lastUpdatePostDateStruct': {'date': '2021-04-26', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2021-02-25', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2021-06-01', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'IL 17A gene polymorphism', 'timeFrame': '6months-1 year', 'description': 'IL 17A'}, {'measure': 'IL 17 F gene polymorphism', 'timeFrame': '6months-1 year', 'description': 'IL 17 F'}], 'secondaryOutcomes': [{'measure': 'Vitamin D', 'timeFrame': '6months-1 year', 'description': 'Serum 25(OH)2 D3'}]}, 'oversightModule': {'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'conditions': ['Recurrent Pityriasis Versicolor']}, 'descriptionModule': {'briefSummary': "Blood samples will be taken from cases presenting with recurrent tinea versicolor , after confirmation of diagnosis by wood's light and KOH examination, for the detection of gene polymorphism in IL17 A and IL17 F.\n\nIn addition , serum samples from patients and controls will be tested for 25(OH)2 D3"}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT'], 'maximumAge': '60 Years', 'minimumAge': '18 Years', 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'Patients with history of disseminated TV, with 2 or more episodes of TV per year.', 'eligibilityCriteria': "Inclusion Criteria:\n\n* \\- Patients with recurrent pityriasis versicolor (active now) and not taking treatment for it.\n* Patients of both genders.\n* Age ≥18 years old.\n\nExclusion Criteria:\n\n* \\- Patients with other cutaneous diseases.\n* Patient's having dandruff (scaly scalp) even if not symptomatizing.\n* Pregnant and lactating females, children, prisoners, cognitively impaired or mentally disabled subjects.\n* Patients with autoimmune diseases.\n* Patients with immunodeficiency diseases.\n* Immunosuppressed patients e.g. HIV, diabetics, organ transplant, malignancy, patients taking immunosuppressive drugs e.g. chemotherapy, cortisone."}, 'identificationModule': {'nctId': 'NCT04769804', 'briefTitle': 'Gene Polymorphism in Tinea Versicolor', 'organization': {'class': 'OTHER', 'fullName': 'Kasr El Aini Hospital'}, 'officialTitle': 'Detection of IL1-7A and IL-17F Gene Polymorphism in Pityriasis Versicolor and Its Relation to Susceptibility to Infections.', 'orgStudyIdInfo': {'id': 'PolymorphismTV'}}, 'armsInterventionsModule': {'armGroups': [{'label': 'Patients with recurrent pityriasis versicolor'}, {'label': 'Healthy age and sex-matched controls'}]}, 'contactsLocationsModule': {'locations': [{'zip': '11956', 'city': 'Cairo', 'state': 'El Manial', 'status': 'RECRUITING', 'country': 'Egypt', 'contacts': [{'name': 'Rana Hilal, MD', 'role': 'CONTACT', 'email': 'rana.hilal@kasralainy.edu.eg', 'phone': '01001488869', 'phoneExt': '+20'}], 'facility': 'Kasr Al Ainy Hospital, Cairo university', 'geoPoint': {'lat': 30.06263, 'lon': 31.24967}}], 'centralContacts': [{'name': 'Rana Hilal, MD', 'role': 'CONTACT', 'email': 'rana.hilal@kasralainy.edu.eg', 'phone': '01001488869', 'phoneExt': '+20'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Kasr El Aini Hospital', 'class': 'OTHER'}, 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Lecturer of dermatology', 'investigatorFullName': 'Rana F Hilal, MD', 'investigatorAffiliation': 'Kasr El Aini Hospital'}}}}